Role of Healthcare Payers and Insurers in the Mass Adoption of Biosimilars
Healthcare payers, including private insurance companies and government health programs, are the most influential drivers of biosimilar adoption. By placing biosimilars on preferred formularies, they can significantly influence which drugs are prescribed. Many payers have recognized that the savings generated from biosimilars can be used to cover other innovative, high-cost therapies. This...
0 Commentaires 0 Parts 173 Vue 0 Aperçu